Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Romero-Aroca

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Medicina Clinica|March 15, 2011
[Risk factors and effects of parenteral drugs on diabetic retinopathy]Pedro Romero-Aroca
Journal of Clinical Medicine|September 9, 2022
Ocular Complications of Diabetes and Therapeutic ApproachesPedro Romero-Aroca
World Journal of Diabetes|August 24, 2011
Managing diabetic macular edema: The leading cause of diabetes blindnessPedro Romero-Aroca
World Journal of Diabetes|October 23, 2013
Current status in diabetic macular edema treatmentsPedro Romero-Aroca
Archivos De La Sociedad Espanola De Oftalmologia|September 4, 2009
[Commentaries to the "Use of non mydriatic retinography to determine the prevalence of diabetic retinopathy in diabetic patients"]Pedro Romero-Aroca
Diabetes Care|October 29, 2010
Targeting the pathophysiology of diabetic macular edemaPedro Romero-Aroca
Journal of Diabetes and Its Complications|June 23, 2004
Risk factors for diffuse and focal macular edemaPedro Romero Aroca, Mercè Salvat, Juan Fernández, et al.
Journal of Clinical Medicine|September 9, 2022
A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-OphthalmologyAlicia Pareja-Ríos, Sabato Ceruso, Pedro Romero-Aroca, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|August 6, 2017
Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumabMarc Baget-Bernaldiz, Pedro Romero-Aroca, Angel Bautista-Perez, et al.
Journal of Clinical Medicine|September 9, 2023
Reply to Fernandez-Vigo et al. Comment on "Torrellas et al. Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser. <i>J. Clin. Med.</i> 2023, <i>12</i>, 1127"Beatriz Torrellas, Alejandro Filloy, Lihteh Wu, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Medicina Clinica|March 15, 2011
[Risk factors and effects of parenteral drugs on diabetic retinopathy]Pedro Romero-Aroca
Journal of Clinical Medicine|September 9, 2022
Ocular Complications of Diabetes and Therapeutic ApproachesPedro Romero-Aroca
World Journal of Diabetes|August 24, 2011
Managing diabetic macular edema: The leading cause of diabetes blindnessPedro Romero-Aroca
World Journal of Diabetes|October 23, 2013
Current status in diabetic macular edema treatmentsPedro Romero-Aroca
Archivos De La Sociedad Espanola De Oftalmologia|September 4, 2009
[Commentaries to the "Use of non mydriatic retinography to determine the prevalence of diabetic retinopathy in diabetic patients"]Pedro Romero-Aroca
Diabetes Care|October 29, 2010
Targeting the pathophysiology of diabetic macular edemaPedro Romero-Aroca
Journal of Diabetes and Its Complications|June 23, 2004
Risk factors for diffuse and focal macular edemaPedro Romero Aroca, Mercè Salvat, Juan Fernández, et al.
Journal of Clinical Medicine|September 9, 2022
A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-OphthalmologyAlicia Pareja-Ríos, Sabato Ceruso, Pedro Romero-Aroca, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|August 6, 2017
Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumabMarc Baget-Bernaldiz, Pedro Romero-Aroca, Angel Bautista-Perez, et al.
Journal of Clinical Medicine|September 9, 2023
Reply to Fernandez-Vigo et al. Comment on "Torrellas et al. Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser. <i>J. Clin. Med.</i> 2023, <i>12</i>, 1127"Beatriz Torrellas, Alejandro Filloy, Lihteh Wu, et al.
Pageof 6